Literature DB >> 17393998

Dementia in a patient with non-paraneoplastic limbic encephalitis associated with relapsing polychondritis.

Max Yan, Wendy Cooper, Clive Harper, Raymond Schwartz.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17393998     DOI: 10.1080/00313020601023989

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  5 in total

1.  Limbic encephalitis associated with relapsing polychondritis responded to infliximab and maintained its condition without recurrence after discontinuation: a case report and review of the literature.

Authors:  Takeshi Kondo; Mamiko Fukuta; Ayumu Takemoto; Yuichiro Takami; Motoki Sato; Noriyuki Takahashi; Tomio Suzuki; Juichi Sato; Naoki Atsuta; Gen Sobue; Yukitoshi Takahashi; Nobutaro Ban
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

2.  Relapsing Polychondritis with Central Nervous System Involvement: Experience of Three Different Cases in a Single Center.

Authors:  Chan Hong Jeon
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

3.  Limbic encephalitis with relapsing polychondritis: persistent white matter lesions and brain atrophy.

Authors:  Zilong Zhu; Decai Tian; Ning Ren; Zhihong Zhao; Xin Wang; Lei Chen
Journal:  J Int Med Res       Date:  2018-11-14       Impact factor: 1.671

4.  Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring.

Authors:  Jun Shimizu; Yoshihisa Yamano; Kimito Kawahata; Noboru Suzuki
Journal:  BMC Rheumatol       Date:  2020-09-11

5.  Comparison of relapsing polychondritis patients with and without central nervous system involvement: A retrospective study of 181 patients.

Authors:  Xiaoyu Cao; Lixiu Zhu; Huijuan Li; Li Jiang; Dong Xu; Jiuliang Zhao; Jiaxin Zhou; Fengchun Zhang; Yong Hou; Xiaofeng Zeng
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.